Opportunity Information: Apply for HRSA 11 094
Apply for HRSA 11 094
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth.
- This funding opportunity was created on Mar 18, 2011 and posted on Mar 10, 2011.
- Applicants must submit their applications by Apr 15, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $700,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Only current Part D WICY grantees are eligible to apply for these funds.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds opportunity (Funding Opportunity Number HRSA 11 094) was a discretionary grant program administered by the Health Resources and Services Administration (HRSA) under CFDA 93.153, Coordinated Services and Access to Research for Women, Infants, Children, and Youth. It was structured as a one-time supplemental funding competition, meaning it was intended to provide additional, time-limited resources on top of existing Part D WICY awards rather than create new standalone projects or expand the program to new organizations.
The central purpose of the funding was to improve access to primary medical care and support services for people living with HIV who fall within the WICY populations: women, infants, children, and youth. The announcement emphasized services that are coordinated and comprehensive, with a strong focus on being culturally and linguistically competent and delivered in a family-centered manner. In practical terms, this points to models of care where medical treatment and supportive services are intentionally connected so clients can move more easily between HIV clinical care and the other services that help them start care, stay in care, and achieve better health outcomes.
A key theme of the opportunity was coordination across service components to reduce gaps in care for families affected by HIV. This includes ensuring that primary HIV medical care is accessible and integrated with supportive services that address real-world barriers such as transportation, childcare needs, language access, stigma, and other factors that can disrupt consistent care. The framing also signals an expectation that grantees tailor services to the needs of diverse communities, including the ability to communicate effectively in the languages used by the people served and to deliver care in ways that are respectful of cultural context and family dynamics.
Eligibility was limited: only current Part D WICY grantees were allowed to apply. This restriction indicates that HRSA intended these supplemental funds to strengthen or expand capacity within already-funded WICY service networks, likely leveraging existing infrastructure, partnerships, and client populations rather than funding new entrants. The funding did not require cost sharing or matching, lowering the barrier to implementation and allowing grantees to focus resources on service delivery improvements.
The total estimated funding amount was 700,000 dollars, with an anticipated 10 awards, suggesting relatively modest supplemental awards designed to address targeted needs, time-sensitive priorities, or specific enhancements to coordinated service delivery. The opportunity was posted March 10, 2011, with an application closing date of April 15, 2011, and it was later archived June 14, 2011. The funding instrument was a grant, and the activity category was health.
For applicants or stakeholders who needed the full announcement or experienced access issues, HRSA provided support through its call center and email contact. The announcement referenced an additional information link hosted on HRSA grants pages, and HRSA directed users to contact the HRSA Call Center via email at CallCenter@HRSA.GOV or by phone at 877 464 4772 for assistance accessing the full notice.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is HRSA 11 094.
Which federal agency administered this program?
This was a discretionary grant program administered by the Health Resources and Services Administration (HRSA).
What CFDA program is this associated with?
It was under CFDA 93.153, Coordinated Services and Access to Research for Women, Infants, Children, and Youth.
What type of funding was this (new program vs. supplement)?
This was a one-time supplemental funding competition. It was designed to provide additional, time-limited resources on top of existing Part D WICY awards rather than create new standalone projects or expand the program to new organizations.
What was the main purpose of the supplemental funds?
The central purpose was to improve access to primary medical care and support services for people living with HIV in the WICY populations (women, infants, children, and youth).
Who are the WICY populations referenced in this opportunity?
WICY refers to women, infants, children, and youth affected by or living with HIV.
What service approach did the announcement emphasize?
The announcement emphasized coordinated and comprehensive services, delivered in a culturally and linguistically competent and family-centered manner.
What does "coordinated and comprehensive" imply in practice?
It points to care models where HIV primary medical care and supportive services are intentionally connected, so clients can move more easily between clinical care and the other services that help them start care, stay in care, and improve outcomes.
What was a key theme or priority area in the opportunity?
A key theme was coordination across service components to reduce gaps in care for families affected by HIV.
What kinds of barriers to care were specifically highlighted?
The opportunity highlighted real-world barriers such as transportation, childcare needs, language access, stigma, and other factors that can disrupt consistent care.
Why does the announcement emphasize cultural and linguistic competence?
It signals an expectation that services be tailored to diverse communities, including the ability to communicate effectively in the languages used by the people served and to deliver care respectfully within the cultural context and family dynamics of participants.
Who was eligible to apply?
Eligibility was limited to current Part D WICY grantees. Only organizations already funded under Part D WICY were allowed to apply.
Could new organizations apply if they were not already Part D WICY grantees?
No. The competition was restricted to current Part D WICY grantees, indicating HRSA intended to strengthen capacity within existing WICY networks rather than fund new entrants.
Did this opportunity require cost sharing or matching funds?
No. The announcement stated that the funding did not require cost sharing or matching.
What was the total estimated amount of funding available?
The total estimated funding amount was $700,000.
How many awards were anticipated?
The opportunity anticipated 10 awards.
What does the estimated funding level suggest about award size?
With an estimated $700,000 total and 10 anticipated awards, the announcement suggests relatively modest, targeted supplemental awards intended for specific enhancements or time-sensitive priorities rather than large-scale program expansions.
What was the funding instrument?
The funding instrument was a grant.
What was the activity category?
The activity category was health.
When was the opportunity posted?
The opportunity was posted on March 10, 2011.
What was the application closing date?
The application closing date was April 15, 2011.
When was the opportunity archived?
The opportunity was archived on June 14, 2011.
Where could applicants find the full announcement?
The announcement referenced an additional information link hosted on HRSA grants pages, and HRSA directed users to contact its call center if they needed help accessing the full notice.
Who should someone contact for help accessing the notice or for technical issues?
HRSA provided assistance through the HRSA Call Center via email at CallCenter@HRSA.GOV or by phone at 877 464 4772.
Browse more opportunities from the same category: Health
Next opportunity: Silvio O Conte Digestive Diseases Research Core Centers (P30)
Previous opportunity: Office of Elementary and Secondary Education (OESE) Striving Readers Comprehensive Literacy Grant Program CFDA Number 84.371C
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 11 094
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 11 094) also looked into and applied for these:
| Funding Opportunity |
|---|
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS11 1102PPHF11 Funding Number: CDC RFA TS11 1102PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Competitive Revision Applications for NIDCR funded Cooperative Agreements (U01) Apply for PAR 11 144 Funding Number: PAR 11 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Centers for Excellence in Clinical Preventive Services (P01) Apply for RFA HS 11 005 Funding Number: RFA HS 11 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| The Infant Immune System Implications for Vaccines and Response to Infections (R01) Apply for RFA AI 11 010 Funding Number: RFA AI 11 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| International Research in Infectious Diseases, including AIDS (R01) Apply for PAR 11 145 Funding Number: PAR 11 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers for Education and Research on Therapeutics (CERTs) Scientific Forum (U19) Apply for RFA HS 11 003 Funding Number: RFA HS 11 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Centers for Education and Research on Therapeutics (CERTs)( U19) Apply for RFA HS 11 004 Funding Number: RFA HS 11 004 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support State Assessment Initiatives Apply for CDC RFA HK07 70205CONT11 Funding Number: CDC RFA HK07 70205CONT11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| HAITI REHABILITATION AND REINTEGRATION OF PERSONS WITH DISABILITIES PROGRAM Apply for USAID HAITI RFA 521 10 033 Funding Number: USAID HAITI RFA 521 10 033 Agency: Haiti USAID Port Au Prince Category: Health Funding Amount: $9,000,000 |
| NINDS Cooperative Program in Translational Research Single Component Research Projects (U01) Apply for PAR 11 153 Funding Number: PAR 11 153 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01) Apply for PAR 11 154 Funding Number: PAR 11 154 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Minority Fellowship Program Apply for SM 11 005 Funding Number: SM 11 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $900,000 |
| CDC Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity Apply for CDC RFA CK11 1106 Funding Number: CDC RFA CK11 1106 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Engaging Indigenous Organizations to Sustain and Enhance Comprehensive HIV/AIDS Services in 26 States of the Federal Republic of Nigeria under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1112 Funding Number: CDC RFA GH11 1112 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $55,000,000 |
| Initiatives Related to the Prevention and Control of Unintentional Injury and Violence Through the World Health Organization (WHO) Apply for CDC RFA CE11 1104 Funding Number: CDC RFA CE11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Evidence to Action for Strengthened Family Planning and Reproductive Health Services for Women and Girls (E2A) Apply for SOL OAA 11 000041 Funding Number: SOL OAA 11 000041 Agency: Agency for International Development Category: Health Funding Amount: $230,000,000 |
| STRENGTHENING HUMAN RESOURCES FOR HEALTH (HRH) PROGRAM Apply for RFA 663 11 000009 Funding Number: RFA 663 11 000009 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $55,000,000 |
| Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R01) Apply for PA 11 165 Funding Number: PA 11 165 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R21) Apply for PA 11 166 Funding Number: PA 11 166 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1) Apply for RFA HL 12 022 Funding Number: RFA HL 12 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 11 094", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.